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Abstract  29 
The sterol metabolome of Acanthamoeba castellanii (Ac) yielded 25 sterols. Substrate screening 30 
of cloned AcCYP51 revealed obtusifoliol as the natural substrate which converts to ∆8,14-sterol 31 
(<95%). The combination of [2H3-methyl]methionine incubation to intact cultures showing C28-32 
ergosterol incorporates 2-2H atoms and C29-7-dehydroporiferasterol incorporates 5 2H-atoms, the 33 
natural distribution of sterols, CYP51 and previously published sterol methyltransferase (SMT) 34 
data indicate separate ∆24(28) - and ∆25(27) -olefin pathways to C28- and C29- sterol products from 35 
the protosterol cycloartenol. In cell-based culture, we observed a marked change in sterol 36 
compositions during the growth and encystment phases monitored microscopically and by trypan 37 
blue staining; trophozoites possess C28/C29-∆5,7-sterols, viable encysted cells (mature cyst) 38 
possess mostly C29-∆5-sterol and non-viable encysted cells possess C28/C29-∆5,7-sterols that 39 
turnover variably from stress to 6-methyl aromatic sterols associated with changed membrane 40 
fluidity affording lysis. An incompatible fit of steroidal aromatics in membranes was confirmed 41 
using the yeast sterol auxotroph GL7. Only viable cysts, including those treated with inhibitor, 42 
can excyst into trophozoites. 25-Azacycloartanol or voriconazole that target SMT and CYP51, 43 
respectively, are potent enzyme inhibitors in the nanomolar range against the cloned enzymes 44 
and amoeba cells. At minimum amoebicidal concentration of inhibitor amoeboid cells rapidly 45 
convert to encysted cells unable to excyst. The correlation between stage-specific sterol 46 
compositions and the physiological effects of ergosterol biosynthesis inhibitors suggests that 47 
amoeba fitness is controlled mainly by developmentally-regulated changes in the phytosterol B-48 
ring; paired interference in the ∆5,7-sterol biosynthesis (to ∆5,7) - metabolism (to ∆5 or 6-methyl 49 
aromatic) congruence during cell proliferation and encystment could be a source of therapeutic 50 
intervention for Acanthamoeba infections  51 
Key words: Acanthamoeba castellanii, sterol methyltransferase, sterol evolution, aromatic 52 
sterols, trophozoite, encystment, ergosterol biosynthesis inhibitor 53 
 54 
Abbreviations: Ac, Acanthamoeba castellanii, SMT, sterol methyl transferase, GC-MS, gas-55 
chromatography-mass spectroscopy, VOR, voriconazole, AZC, 25-azacycloartanol, RRTc, 56 
retention time of unknown to retention time of cholesterol in GC. Mya, million years ago.  57 
Highlights:  58 
1. Acanthamoeba castellanii cells generate 25 sterols, a mixture of 4-methyl intermediates 59 
and ∆5-final products, affording a biosynthetic pathway recurrent from an ancient algal 60 
predecessor; separate intermediates via the ∆24(28) -methyl olefin route and ∆25(27) - ethyl 61 
olefin route determine the C28- and C29-sterol balance in the amoeba.  62 
2.  Cloned AcCYP51 favors obtusifoliol as substrate, but can convert cycloeucalenol weakly 63 
to ∆14-product.  64 
3. ∆5,7 - and ∆5-sterols are differentially correlated to trophozoite growth and mature cyst 65 
viability and excystment, respectively, while 6-methyl aromatic sterols are a chemical 66 
signature indicative of encysted cells on the path to death. 67 
4. Voriconazole inhibits AcCYP51 as other azoles and 25-azacycloartanol inhibits AcSMT 68 
in the low nanmolar range; these drugs are potent inhibitors of trophozoite growth and 69 
impair encystment toward viable cyst production in the range of 500 nM to 3 µM.  70 
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1. Introduction 71 
Sterol synthesis is a basic metabolic pathway of eukaryotes giving rise to essential membrane 72 
components. The biosynthesis pathway is typically divided into three routes, two of which 73 
characterize the phytosterol biosynthesis pathways in land plants and fungi yielding C29-74 
sitosterol (24α-ethyl group) and C28-ergosterol (24β-methyl group), respectively, and in animals 75 
yielding C27-cholesterol (Fig. 1) [1-4]. These contemporary biosynthetic pathways retain 76 
ancestral features along with novelties specific to their particular lineages. Notably, the 77 
protosterol product of the 2,3-oxidosqualene synthase yielding cycloartenol or lanosterol 78 
associates phylogenetically to plant-animal divisions while the substrate acceptability and 79 
mechanisms of individual enzymes catalyzing completion of the pathway to ∆5-sterols reveal 80 
relatedness or divergence in catalytic competence across kingdoms [5, 6]. For phytosterols 81 
generating diversity, the size, location and direction (α- or β-orientation) of the side chain C24-82 
alkyl group correlate to plant-fungal divisions or to more- or less-advanced in descent. Structural 83 
features common to sterols are a cyclopentanoperhydrophenanthrene ring system, polar C3-OH 84 
group and intact side chain of 8 to 10-carbon atoms. These characteristics contribute positively to 85 
the molecule’s overall flat shape, length and amphipathic character relevant to the architectural 86 
suitability of sterols in membranes [7]. Alternatively, there can be harmful features in 87 
intermediates that are removed during the normal course of metabolism. For example, the C4-88 
geminal methyl groups and C14-methyl group on the protosterol, eliminated to yield ∆5-sterols, 89 
are known to affect the hydrogen bonding strength of the C3-OH group and planarity of the α-90 
(back) face of the sterol nucleus, respectively; when intermediates that possess these features 91 
accumulate in the cell the result can be detrimental to sterol homeostasis that thereby, interferes 92 
with growth and maturation [8-10]. 93 
Despite the prevailing hypothesis suggesting progressive structural modifications in the 94 
protosterol formed by prokaryotes parallels a gradual cholesterol evolution in response to 95 
increases in the atmospheric concentration of oxygen [11-13] recent chemical analysis on the 96 
origin of these compounds indicate a complete sterol biosynthesis to ∆5-products may have 97 
existed in the most primitive eukaryotes, evidenced in the presence of cholestane and its C28- to 98 
C30-carbon homologs in molecular fossils found in rocks and formations between 750 Mya to 99 
1,000 Mya [14]. Additionally, phylogenomic analysis shows the genes of 13 sterolic enzymes 100 
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yielding these steranes could be codified in the genomic organization of the last eukaryotic 101 
common ancestor (LECA) approximately 2.45-2.32 Mya [15, 16] with orthologous prokaryotic 102 
enzymes likely formed during the Great Oxidation Event by horizontal gene transfers [17, 18]. 103 
Based on this new information, we surmise competing phylogenies constructed from these 104 
characters could reasonably describe the punctuated and recurrent evolution of sterol 105 
biosynthesis to amoeba ergosterol deeply rooted in primary metabolism of the LECA [19, 20]. 106 
However, relevant to the understanding of sterol biosynthesis in Acanthamoeba for the purpose 107 
of inhibition, the phyla-specific canonical routes to alternate sterol products must also be 108 
considered, because different steps in sterol metabolism – sterol side chain or nucleus revisions- 109 
could interface uniquely through stage-specific structural adjustment during the amoeba life 110 
history, as reported can occur in land plants [21, 22] to yield ergosterol convergence (Fig. 1).  111 
Acanthamoeba spp. has a number of particularly advantageous characteristics for research on 112 
sterol function and evolution. In the first place, the differentiation process originating in the 113 
trophozoite and passing through a pseudocyst, i.e., an intermediate structure composed of a wall 114 
that may not protect against adverse conditions [23, 24], can yield multiple cyst types, including 115 
1) viable cysts with a resistant double-layered outer wrinkled ectocyst and inner endocyst and 2) 116 
a mixture of non-viable cysts of apoptotic cells that possess a fragile cell wall and dead cells 117 
generated from autophagocytosis [25]. These studies further show azolic inhibitors-voriconazole 118 
can prevent trophozoite growth as well as activate an encystment pathway with a final trajectory 119 
ending in programed cell death [26]. Ergosterol biosynthesis inhibitors with various structures 120 
can therefore be administered and the effects on growth and differentiation measured in 121 
correlation to changes in sterol biosynthesis. Intriguingly, the unikont Acanthamoeba is distinctly 122 
different from fungi and bikont protozoa (kinetoplastids) in their sterol biosynthesis capabilities. 123 
The variant pathways for C28-ergosterol biosynthesis in parasitic protozoa also differ from the 124 
C27-cholesterol biosynthesis in the human host where sterol C24-methylation is lost [27].  125 
The ability of Acathamoeba spp to synthesize a plant-based pathway of cycloartenol to ∆5- and 126 
∆5,7-24β-C28- and C29-alkyl sterols was discovered in the early 1980’s by Raedorstorff and 127 
Rohmer [28, 29]. These researchers together with the Korn group demonstrated the amoeba 128 
ergosterol and 7-dehydroporiferasterol can convert to uncommon C28 - and C29-phenanthrene 6-129 
methyl aromatic sterols [30, 31]. The Acanthamoeba system has been exploited in the 130 
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collaborative laboratories of Kelly and Nes [32, 33] and more recently by Roberts and coworkers 131 
[34]. However, unlike the Rohmer and Korn groups, the more recent authors [34] have 132 
concluded that Acanthamoeba operates a fungal-based pathway of lanosterol to ergosterol and 133 
the protozoan is unable to synthesize C29-sterols. Our own preliminary work corroborated the 134 
original findings, and the purpose of the present paper is to document this in detail and to expand 135 
the study to encompass a more comprehensive evaluation of the biosynthetic enzymes and 136 
steroidal nuggets expressed variably at stage-specific times in Acanthamoeba. The approach used 137 
in our investigation has been chosen to validate the ergosterol biosynthesis pathway from 138 
cycloartenol and the existence of a new ∆25(27) -C29-sterol biosynthesis pathway in amoeba that 139 
recapitulates the green algal sterol biosynthesis pathway to C29-sterols.  140 
Another reason for choosing Acanthamoeba was the critical factors in target deconvolution using 141 
sterolomics, bioinformatics and genetic technologies that led to enzyme-based strategies for 142 
manipulating the ergosterol biosynthesis pathway in this and related parasitic protozoa. These 143 
various investigations provide new chemical starting points against our target enzymes- the 144 
Acanthamoeba castellanii (Ac) sterol C14-demethylase (CYP51) and sterol C24/C28-145 
methyltransferases (SMT). Inhibition of either enzyme by a rationally designed tight binding 146 
inhibitor rapidly yields trophozoite death [33]. The only real uncertainties left about the 147 
importance of phytosterol biosynthesis/metabolism in Acanthamoeba  are: (i) can the sterol 148 
composition change during the amoeba life cycle, (ii) has phylogenetics influenced formation of 149 
separate routes to C28- and C29-sterols, (iii) to what extent is ergosterol biosynthesis during the 150 
Acanthamoeba encystment-excystment cycle vulnerable to inhibitors and (iv) what role is played 151 
in Acanthamoeba physiology by changing the sterol B-ring structure from ∆5,7 - to ∆5 - or 6-152 
methyl aromatic group? 153 
In this study, the pattern of sterol biosynthesis and accumulation in Acanthamoeba against 154 
ultrastructure and viability of the cells was determined at various stages of amoeba proliferation 155 
and encystment. In addition, we examined the physiological role of the uncommon 6-methyl 156 
aromatic sterol structures generated by the amobea through use of enzyme inhibitors and the 157 
yeast sterol auxotroph GL7. The results define the biosynthetic factors that control the changes in 158 
sterol compositions associated with amoeba differentiation, and provide the necessary foundation 159 
for further regulatory studies at the biochemical and molecular levels. Given the therapeutic 160 
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importance for CYP51 and SMT as chokepoint enzymes in Acanthamoeba and other parasitic 161 
protozoa, knowledge of the diversity and function of terminal C28- and C29-sterols in the 162 
trophozoite and encysted cell can be of value in developing new inhibitor chemotypes to treat 163 
amoeba diseases.   164 
 165 
 166 
 167 
 168 
 169 
 170 
 171 
 172 
 173 
 174 
 175 
 176 
 177 
 178 
 179 
 180 
 181 
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2. Materials and methods 190 
2.1. Strain and culture conditions. Acanthamoeba castellanii strain ATCC 30010 was inoculated 191 
into tissue culture 25 ml T-flasks prepared with ATTC media 712. Cells were cultured axenically 192 
in 5 ml static culture at 25 0C with occasional hand shaking to keep cells in suspension. 193 
Continuous cultures were maintained by subculture of 4-5 day growth arrested cells into fresh 194 
medium. Growth experiments to establish the growth curve and for sterol analyses were typically 195 
carried out using 1 x 104 trophozoites (< 90%) or cysts derived by the methods below. The 196 
number of individual amoeba distinct from encysted cells that possess a double wall per ml was 197 
determined microscopically. For cell aggregates a best effort was made to count the number of 198 
individual encysted cells in the clump. Morphological changes and encystation ratios were 199 
calculated by counting trophozoite to cysts using a Neubauer hemocytometer under an Olympus 200 
CH-2 compound light microscope and in separate observations cell differentiation was detected 201 
with an inverted microscope monitored daily for 2 weeks. Cells were pelleted by centrifugation 202 
for 5 min at 5,000 g. Cell viability was checked by trypan blue exclusion method.  203 
2.2. Induction of encystment. To generate viable cysts capable of excystment, equivalent to 204 
resting or dormant cysts, three different approaches were employed. Method-1, using wild-type 205 
trophozoites, encystment was induced naturally by allowing the early growth arrested cultures 206 
(ca. 4-5 day synchronous cultures) to deplete essential growth nutrients required in metabolite 207 
biosynthesis. In a second approach encystment was forced by two replacement methods. 208 
Method-2 is salt- induced encystment and was used by Korn et al. and Mehdi and Garg [24, 30, 209 
35]. Briefly, trophozoites were resuspended in medium containing 1 mM MgCl2 to a cell 210 
concentration of approximately 6.5 x 106 cells/ml. The culture was incubated in a 30 0C shaker at 211 
150 rpm for 2 days. The cells were collected and treated with 1% sodium dodecyl sulfate (SDS) 212 
solution for 30 min at room temperature to remove trophozoites, fragile encysted cells and cell 213 
debris. The resulting SDS-resistant cysts were washed with PAGE’s saline solution 5 times and 214 
analyzed for sterols. Method 3 is starvation-induced encystment where the amoebae are 215 
maintained on an agar-embedment system for 2-4 weeks [23]. Encystment synchrony was 216 
evaluated morphologically using a combination of inverted microscopy, light microscopy and 217 
electron microscopy. More than 90-95% of the cells formed from these conditions yielded 218 
encysted cells with features representative of resting or dormant cysts. Resting cysts generated 219 
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by the natural and replacement methods were determined viable by their ∆5-sterol profile, and in 220 
each case yielded similar excystment activities of about 100%. Typically, the viable cysts at the 221 
end of these experiments appeared as single cells in light microscopy either on the solid or in 222 
liquid medium. A third approach was used to promote encystment by administering drugs to the 223 
medium. 224 
2.3. Trophozoite toxicity assay. To determine the effect of the test compounds on the growth of 225 
Acanthamoeba, trophozoites, approximately 1 x 105 cells, were inoculated into 24 well (4 x 6) 226 
microtiter plates of 3 ml final volume taking the inoculum from cells grown in the T-flask 227 
continuous culture system. Stock inhibitor concentrations were prepared in dimethylsulfoxide 228 
(not to exceed 1% solvent) and as relevant serially diluted to final concentrations in wells that 229 
ranged from 16 nM to 30 µM (approximate to the end point for inhibitor studies administered to 230 
human epithelial kidney cells [32, 33]. Control wells containing medium and 1% DMSO solvent 231 
had no effect on the cell growth. The microliter plates were incubated at 25-0C for 48 hr and the 232 
resulting number of trophozoites to cysts counted at the end of the incubation using the 233 
hemocytometer. The percentage of viable tophozoites following to different concentrations of 234 
inhibitors was determined by the trypan blue exclusion method. The 50% effective does (IC50) 235 
value of inhibitors against tophozoite growth under the stated assay conditions was determined 236 
by linear extrapolation using GraphPad Prism (GraphPad Software Inc., CA). Cells stained blue 237 
were considered non-viable while live cells were unstained. These experiments were carried out 238 
in triplicate and at different time points. The drug concentration responsible for the minimum 239 
ameobacidal activity (MAC) was defined as the lowest concentration of the inhibitor with no 240 
visible live trophozoites, as determined by visual inspection of the treated cultures using the light 241 
microscope following trypan blue staining and inverted microscope which confirmed cell death 242 
by the absence of trophozoite cells and notable accumulation of cell debris. Observations were 243 
performed in triplicate x 2 using light microscope for counting cells. There was excellent 244 
agreement (≤10% variation for any data point) in the growth response to inhibitors in the two 245 
independent trials.  246 
2.4. Time-dependent killing. A log-phase culture of Trophozoites was seeded into 24-well plates 247 
as described above. Cells were then challenged with inhibitors at previously determined MAC 248 
concentrations. At 12 hr intervals, aliquots were removed and counted and cell viability 249 
9 
  
determined; at 48 hr remaining cells were pelleted and resuspended into fresh medium and 250 
allowed to incubate for another 5 days and the cells counted to determine trophozoite 251 
proliferation and analyzed for sterol content. Experiments were performed with biological 252 
replicates. A metabolic marker was used to assess viable cells by means of GC-MS analysis. 253 
Viable trophozioites were associated with the production of ergosterol/7-dehydroporiferaterol 254 
and viable cysts were associated with poriferasterol production and cells in the death mode were 255 
associated with  steroidal aromatics as discussed in the text.   256 
2.5. Cysticidal assay. Cysts, generated by the methods above, or derived from inhibitor 257 
treatment, were incubated with the anti-amoeba drug under the same assay conditions described 258 
for ameobacidal assay. Growth was defined as the presence of excysted trophozoites found 259 
growing in 24 well plates or 5 ml T-flasks after 5 days of growth.  260 
2.6. Chemical and instrumental analysis. The source of sterol substrates and steroidal inhibitors 261 
evaluated in this study is described in earlier papers [8, 20, 36]. Voriconazole was purchased 262 
from Sigma. All sterols were purified by HPLC to < 95% by GC analysis. S-adenosyl-L-263 
methionine (SAM) chloride salt was purchased from Sigma, [methyl-3H3]SAM (specific activity 264 
10-15 Ci/mMol, and diluted to 10 µCi/µMol, tetraosylate (methyl-2H3]SAM (99% atom 265 
enrichment) purchased from S/D/N isotopes (Pointe-Claire, QC), L-[methyl-2H3]methionine 266 
(Sigma). The Bradford protein assay kit was purchased from Bio-Rad and isopropyl-1-thio-β-D-267 
galactoside (IPTG) purchased from Research Products International Corp. DNA synthesis 268 
inhibitor 5-fluor-2-deoxyuridine (FUdR) was purchased from MP Biomedicals LLC. All other 269 
reagents and chemical were from Sigma or Fisher unless otherwise noted.  270 
Instrumental methods have been reported previously [19, 20]. Briefly, 1H-NMR spectra were 271 
recorded in CDL3 at ambient temperature using a Varian Unity Inova 500 MHz spectrometer; 272 
chemical shifts (δ, ppm) are referenced to chloroform, (δ, 7.26 ppm). Mass spectra were obtained 273 
on a Hewlett-Packard 6890 GC-HP 5973 MSD instrument (electron impact, 70eV, scan range 274 
50-550 amu). HPLC was carried out at room temperature using a Phenomenex Luna C18-column 275 
(250 mm x 4.6. mm x 5 µM) connected to a diode array multiple wavelength diode array detector 276 
with methanol as eluent. Capillary GC (0.25 mm i.d, by 30 m fused silica column coated with 277 
Zebron ZB-5 from Phenomenex) was operated at a flow rate of He set at 1.2 ml/min, injector 278 
port at 250 0C, and temperature program of initial 170 0C, held for 1 min, and increased at 20 279 
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0C/min to 280 0C. GC analysis of sterols is reported as RRTc values referring to the retention 280 
time of sample GC peak to retention time of cholesterol peak which moved typically in the 281 
chromatogram at 13.8 min or slightly different to 14.5 min depending on whether the column tip 282 
was clipped due to age issues. In HPLC samples were separated on a Phenomenex Luna C18-283 
column (250 mm x 4.6 mm x 5 cm) connected to a diode array multiple detector with samples 284 
eluted with methanol; the αc of the sterol is the elution time of compound relative to the elution 285 
time of cholesterol, which is 20.6 min. In sterol analysis, product distributions were determined 286 
by approximate integration of chromatographic peaks, experiments were performed in biological 287 
replicates with excellent agreement between trials (>95%). Thin layer chromatography was 288 
performed on 10 x 20 cm, 250 µM silica plates (Baker) developed twice in benzene-ether (85/15, 289 
v/v). 290 
2.7. Cell metabolite identification. Typically, small-scale amoeba cultures were harvested 291 
different points along the growth curve in the presence and absence of steroidal inhibitor and 292 
azole at MAC concentrations of the compound. Control or treated cultures in 5 ml or 10 ml 293 
medium dispersed in 25 ml T-flasks were inoculated with trophozoites (90%) or resting cysts 294 
(100%) and cultured for the desired time without shaking and sterol analyzed at the end of the 295 
incubation period. Independently, trophozoites were incubated in the 24-well plate system 296 
containing 1 ml total medium and after 48 h treatment the sterol composition determined by GC-297 
MS analysis. Cell pellets were split with an internal standard of 5α-cholestane added to one of 298 
the cell pellets for determination of sterol amounts in cells. Cells were saponified with 10% 299 
methanolic KOH extracted with hexanes and the neutral lipids routinely analyzed by GC-MS for 300 
structure determination and quantification. Components were identified by comparison of 301 
retention times in GC and HPLC and mass spectra with authentic standards in our own collection 302 
[19, 20, 22, 37] and were quantified by comparison of detector response with that of the internal 303 
standard. As relevant preparative scale incubation were carried to obtain a subset of amoeba 304 
sterols for 1HNMR analysis. 305 
2.8. Scanning (SEM) and transmission (TEM) electron microscopy. SEM: Prior to fixation, 306 
control and treated cell pellets were rinsed in 10% phosphate buffer solution, and centrifuged 307 
again to remove any salts that would give false images of crystalline-like structures in the 308 
background. After resuspension in buffer, cells were adhered onto poly-L-lysine-coated glass 309 
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coverslips and subsequently fixed with a solution of 2.5% glutaraldehyde in 0.05M cacodylate 310 
buffer. Samples were postfixed for 10 min in 1.5% OsO4, dehydrated in ethanol, and critical 311 
point dried with liquid CO2. The cells were then coated with technics hummer V coater and 312 
observed under a Zeiss 540 scanning electron microscope.    313 
TEM: Similar to SEM, prior to fixation, control and treated cell pellets, that included primarily 314 
trophozoites or cysts depending on the treatment, were rinsed in 10% phosphate buffer solution, 315 
and centrifuged again. After resuspension in buffer, cells were adhered onto poly-L-lysine-316 
coated glass coverslips and subsequently fixed in a solution of 2.5% glutaraldehyde in 0.05M 317 
cacodylate buffer. After fixation, the cells were post-fixed with 1% (wt/vol) OsO4, dehydrated 318 
with ethanol and acetone and embedded in epoxy resin. Ultrathin sections (1 micron) were 319 
contrast stained with uranyl acetate and lead acetate and observed under a Hitahci H-8100 320 
Transmission Electron Microscope fitted with AMT side mount digital camera.  321 
2.9. Induction of aromatic sterol synthesis. Following the protocol of Korn [30] enabling the 322 
rapid induction of aromatase activity through cell disruption coupled to osmotic stress, control 323 
amoeba cell pellets harboring approximate 1 x 107 cells/ml composed mostly of trophozoites 324 
(90%) were equilibrated for 20 min at zero degrees in 0.002 M CaCl2 -0.001 M Tris buffer (pH 325 
7.0) and homogenized with three gentle strokes of a Douce homogenizer. Samples of 20 ml were 326 
incubated at 18 degrees for 6 h. At the end of the incubations, the lipids extracted with 327 
chloroform-methanol (2:1. v/v). The solvent was evaporated and the resulting organic layer 328 
analyzed by GC-MS/HPLC-UV or in separate study, preparative scale studies were carried out to 329 
isolate the major sterol products for 1HNMR.  330 
2.10. Determination of AcCYP51 substrate affinity and product outcome 331 
The expression of pCWori+:AcCYP51 construct in E. coli has been described previously [32]. 332 
Cytochrome P450 concentration, determined by reduced carbon monoxide difference spectra, 333 
and ligand binding studies [6, 38]. The dissociation constant of the enzyme-ligand complex (Kd) 334 
for each sterol or azole was determined by non-linear regression (Levenberg-Marquardt 335 
algorithm) using a rearrangement of the Morrison equation for tight ligand binding and the 336 
Michaelis-Menten equation when ligand binding was no longer tight [38]. Stock 2.5 mM sterol 337 
solutions were prepared in 40% (w/v) of 2-hydroxypropyl-b-cyclodextrin (HPCD). All spectral 338 
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determinations were determined in triplicate. Curve-fitting of ligand binding data were 339 
performed using the computer program ProFit 6.1.12 (QuantumSoft, Zurich, Switzerland). 340 
Spectral determinations were made using quartz semi-micro cuvettes with a Hitachi-U 3310 341 
UV/Vis spectrometer (San Jose, CA). CYP51 enzyme activity from 10 min incubation was 342 
determined in triplicate using a CYP51 reconstitution assay system (0.5 ml final volume) 343 
composed of 1.14 µM AcCYP51, 2.81 µM Aspergillus fumigatus (AfCPR1-Q4WM67) 344 
cytochrome P450 reductase, 50 mM sterol substrate, 50 mM dilauryl phosphatidylcholine, 4% 345 
HPCD, 0.4 mg ml-1 isocitrate dehydrogenase, 25 mM trisodium isocitrate, 50 mM NaCl, 5 mM 346 
MgCl2 and 40 mM MOPS (pH, 7.2). In a preliminary study to establish approximate Km and Kcat 347 
kinetic constants for obtusifoliol against pure Ac C14-demethylase, reactions were carried out at 348 
37 0C with 1.14 µM recombinant CYP51 and 2.74 µM Homo sapiens CPR (as redox partner) at 349 
sterol concentrations of 6.25, 12.5 25, 50, 75 and 100 µM for 20 min. In a separate set of 350 
experiments, the kcat for AcCYP51 against AfCPR1 was determined under assay conditions 351 
performed with the HsCPR redox partner. Because the turnover number for obtusifoliol was 352 
distinctly low against HsCPR redox partner we chose to evaluate sterol structure-activity against 353 
the redox partner of AfCPR. Enzyme-generated products were recovered by methanolic KOH 354 
saponification followed by extraction with 2 x 3 ml n-hexane, and then evaporation to dryness 355 
using a vacuum centrifuge. Product outcome was determined by GC-MS analysis of the free 356 
sterol. Competition experiments to establish IC50 of azole against obtusifoliol were carried with 357 
the AcCYP51 and redox partner HsCPR.  358 
2.11. AcSMT Inhibition studies  359 
Enzymatic assay conditions with soluble (cloned) Ac24-SMT or Ac28-SMT enzyme preparation 360 
and inhibition constant (IC50) determination against natural substrate and the 25-azacycloartanol 361 
inhibitor were essentially as described in the previous report [33]. Briefly, IC50 values were 362 
determined from a dose-response curve against variable inhibitor concentrations in the range 0 363 
nM, 3.9 nM to 1 µM in the presence of fixed-saturation- concentration of sterol acceptor (100 364 
µM) and coenzyme (150 µM). Assays were performed in triplicate with less than 10% deviation. 365 
IC50 values were determined by standard graphical procedures for which computer-assisted 366 
linear regression analysis afforded correlation coefficients greater than 0.95 in a cases. 367 
Conversion of IC50 value to Ki as dissociation constant, based on the experimentally deduced 368 
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kinetic properties of cycloartenol (24-SMT) or 24(28)-methylene lophenol (28-SMT) and 25-369 
azacyclartanol was accomplished using the Cheng-Prussoff equation [38].  370 
2.12. GL7 growth  371 
 Sterol structure-membrane response effects were carried out using the Saccharomyces 372 
cerevisiae strain GL7 with a defective 2,3-oxidosqualene to lanosterol synthase (LAS) 373 
auxotrophic for ergosterol, its natural membrane insert [8, 39]. GL7 was cultured on 5 mg/l and 374 
Tween 80 (15 ml/l) in yeast-peptone-dextrose medium for 72 h affording growth arrest typical of 375 
wild-type yeast of 1 x 108 cells/ml [8].  376 
 377 
 378 
 379 
 380 
 381 
 382 
 383 
 384 
 385 
 386 
 387 
 388 
 389 
 390 
 391 
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RESULTS 392 
3.1 Development of novel steroidogenesis patterns with growth and differentiation.  393 
A single cohort of viable cysts cultured on optimal growth conditions linked to extrinsic cues of 394 
salt stress or a decrease in carbon sources [23, 24] was used to observe excystment to replicative 395 
senescence-death and any associated sterol patterning. The initial experiments to observe 396 
differentiation included inoculum obtained from cysts determined to possess exlcusively∆5-397 
sterols - brassicasterol and poriferasterol. Trophozoite proliferation, from 104 resting cysts/ml, 398 
followed a logarithmic course with a doubling time of 2.8 h. There seemed to be a slight 399 
induction period related to excystment phase of approximate 8-12 h yielding trophozoites. 400 
Amoeba cell proliferation reached growth arrest at approximately 3 days affording a cell density 401 
140 thousand cells/ml (Fig. 2, Panel A). As the amoeba continued in stationary phase, they began 402 
to progressively convert to encysted cells of mixed population of live and dead. The total cell 403 
number decreased with culture age as did the fresh weight of cultures by roughly a factor 10 at 404 
day 7 (Fig. 2, Panel B-inset). Continued incubation of the encysted cells for a month led to dead 405 
cells by trypan blue staining and to further decrease in the number of encysted cells by another 406 
factor of ten to about 104/ml cysts remaining. Because some media preparations for amoeba 407 
growth include fetal bovine serum (FBS), which we determined contains 10µM cholesterol, we 408 
added FBS as described in the American Type Culture Collection growth media or added 10µM 409 
cholesterol in DMSO to our growth media. In either case, the cholesterol supplement had only a 410 
minor stimulation effect on trophozoite growth.  411 
To assess the conservation or change in sterol composition associated with differentiation, cells 412 
were harvested at 6 different stages in the excystment-trophozoite-encystment cycle at days 1, 2, 413 
3, 4, 7 and 1 month post-inoculation. The analysis demonstrated developmental changes in cell 414 
morphology and viability were accompanied by remarkable changes in steroidogenesis and 415 
metabolism. First, in what may be considered the amoeba growth phase, in the early logarithmic 416 
phase of growth in days 1 to 1.5 the C30 and C31-cyclopropyl sterols -cycloartenol and 24(28)-417 
methylene cycloartanol accumulate (Fig 2 and Suppl. Fig. 1), followed in logarithmic growth in 418 
days 2 to 3/3.5 by a shift to ∆5,7-C28- and C29-sterol end product formation in approximate 5 to 7 419 
ratio (Fig. 2, Panel B and Suppl. Fig. 2).  420 
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At day 4 where the total cell number was similar to that at day 3, there was a mixed population 421 
of trophozpoite and cysts and the sterol composition of the pelleted cells was a mixture of 422 
ergosterol, 7-dehydroporiferasterol, brassicasterol and poriferasterol roughly in a 50:50 ratio of 423 
∆5,7 to ∆5-sterols. At day 7, most trophozoites had encysted (90% of total cells). The fresh weight 424 
of the cell pellet had decreased by a factor of 3 and the sterol composition of the encysted cells 425 
had reverted back to that of inoculum of ∆5- C29-sterol (90% of total sterol). (Figure 2, Panel B 426 
inset). At one-month incubation, after the remaining encysted cells had opportunity to excyst and 427 
proceed to trophozoite and then encyst again in cyclic fashion using up the carbon sources, most 428 
encysted cells were dead and contained predominantly C28- and C29- 6-methyl aromatic sterols, 429 
which we refer to as amebasterol-1 and amebasterol-2, respectively. These sterols were 430 
previously observed by Korn and Rohmer in Acanthamoeba as minor compounds (trace to 5% 431 
total sterol) [28-30, 40] from growth arrested cultures. We confirmed the structure of the major 432 
Ac sterols, as well as that of brassicasterol which is a newly characterized Ac sterol, through an 433 
examination of their chromatographic and spectral properties reported in Figure 3 (Suppl. Table 434 
1 for 1HNMR analysis).  435 
With this knowledge, the morphology and ultrastructure characteristics of trophozoites and 436 
encysted cells obtained from control (and subsequently treated cells) were determined. In light 437 
microscopy, inoculum cells generated by Method 2 against SDS (Materials and Methods) were 438 
found to possess the double-wall feature, and in transmission electron microscopy the 439 
encystment was evidenced in ultrastructure showing a nucleolus with a dense droplet in the cyst 440 
center, dense cytoplasm packed with lipid droplets, spherical mitochondria (M) and 441 
autolysosomes (A) that appear as large basophilic granules. Our observations, in agreement with 442 
Bowers and Korn [24], showed the mean diameter of rounded amoeboid cells were 443 
approximately  26.5 ± 0.17 µ whereas the mean cytoplasmic diameter of cysts was 16.2 ± 0.13 µ. 444 
The decrease in surface area during encystment of a cell of median diameter was more than 65% 445 
while the decrease in median cell volume was approximately 80%, suggesting significant loss of 446 
cell membrane from amoeba to true cyst. The sterol content in trophozoite and true cyst was 12 447 
pg/cell and 4 pg/cell, respectively. Thus, there is both a distinct loss in total sterol and a marked 448 
metabolism of preformed ∆5,7-sterol as trophozoite converts into the true cyst form. These sterol 449 
modifications correlate to the different membrane requirements of non-encysted and encysted 450 
cells capable of excystment (Figure 2). Once true cysts differentiate into trophozoites, the 451 
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resulting amoeba, observed to synthesize ergosterol and 7-dehydroporiferaterol, were examined 452 
by light and electron microscopy. These non-encysted amoebae were shown to contain typical 453 
cytoplasmic organelles, such as a nucleus with a prominent nucleolus, an abundant rough 454 
endoplasmic reticulum, mitochondria, vacuoles and lipid droplets and showed surface 455 
protrusions -acanthapodia, durable double wall of smooth ectocyst and a round endocyst (Fig. 2, 456 
Panel C).  457 
3.2. Medium-replacement induced-encystment can lead to distinct cell types of characteristic 458 
sterol compositions. 459 
To determine whether the unusual ∆5-sterol and 6-methyl aromatic sterol profiles observed in the 460 
stationary phase growth were associated with distinct cyst populations, we initiated encystment 461 
by Method 2. The salt stressed trophozoite cultures spontaneously encysted yielding some cell 462 
debris. GC-MS analysis of the pellet extract revealed 21 sterols (Suppl. Fig. 2, Panel E and Table 463 
1) which is the most complex sterol composition reported for not only the amoeba but for 464 
protozoa generally. Many of these sterols represent co-metabolites and by-products. Of interest 465 
was the experimentally induced encystment of amoeba yielded a sterol mixture of ∆5,7-sterols, 466 
∆5-sterols and 6-methyl aromatic sterols. Notably, no significant trpohozoites were detected 467 
microscopically, yet there is a significant amount of ergosterol and 7-dehydroporiferasterol in the 468 
sterol mixture suggesting that a subset of encysted cells could possess ∆5,7-sterols. As the 469 
encysted cells were processed further through SDS-treatment, the cells that remain contain 470 
predominantly brassicasterol and poriferasterol by GC-MS analysis (Supple Fig. 2, Panel F); 471 
these cells are viable and can excyst completely to trophozoites in enriched medium in 12 h. We 472 
surmise the salt step can create mixed populations of encysted cells; one population is composed 473 
of fragile double walls and membranes composed of ∆5,7-sterols or aromatic sterols and a second 474 
population is composed of resistant double-wall structures and membranes composed of ∆5-475 
sterols.  476 
A crucial observation made by the Korn group to prepare an abundance of 6-methyl aromatic 477 
sterols of the phenanthrene skeleton was to generate a cell-free system of Ac in high salt solution 478 
yielding a microsomal (membranes) subcellular fraction. Under these conditions, the ergosterol 479 
and 7-dehydroporiferasterol rapidly convert in stoichiometric fashion to amebasterol-1 and 480 
amebasterol-2; the aromatic compounds remain membrane-bound [30]. The relevance of the 481 
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Korn study is to show both that the phenanthrene steroids can be easily obtained in amounts 482 
necessary for structure determination and that these aromatic compounds can associate with the 483 
endoplasmic-plasma-membrane fraction of microsomes in intact cells. Notably, this approach 484 
used by Rohmer on the related Acanthamoeba species-polyphaga yielded sufficient compound to 485 
be characterized by 13C/1H-NMR to prove the structure and stereochemistry of the metabolites as 486 
new class of steroids [31]. We repeated these studies and observed Ac homogenates generate 6-487 
methyl aromatic sterols from ∆5,7 -sterols in amounts reported by Korn over the 6 h incubation 488 
period. The 6-methyl aromatic sterols can remain stable for at least 2 months (Suppl. Figure 2, 489 
Panels G and H).  490 
3.3. Catalytic competence of AcCYP51relative to Ac24-SMT and Ac28-SMT.  491 
The functional expression in E. coli of pC Wori+:AcCYP51 construct and wild-type cDNA of 24-492 
SMT and 28-SMT have been described previously [32, 33]. To elucidate the diversity of 493 
substrate preference that could influence the order of intermediates in C28- and C29- sterol 494 
synthesis, eleven 14-methyl sterols were evaluated for substrate recognition by AcCYP51 (Table 495 
2, Suppl. Fig. 3 to 6). When the redox partner for AcCYP51 activity was AfCPR1 the rate of 496 
formation of product was greater by a factor of 10 compared to using the HsCPR redox partner 497 
affording approximately 7.6 ± 0.05 min-1. Consequently, we used the AfCPR1 redox partner to 498 
determine structure-activity.  499 
After incubation in the usual way, no metabolism occurred with cycloartenol, whereas 500 
obtusifoliol was fully metabolized by AcCYP51 under the same conditions as evidenced in GC-501 
MS analysis showing the ∆8,14 –product in 95% yield (Suppl. Fig. 4). Because the rate of product 502 
formation against the AfCPR1 partner was much higher than when using the HsCPR redox 503 
partner, we could now detect some small conversion of cycloeucalenol. This was evident in two 504 
ways; in catalytic assay to establish competence afforded a rate of 0.04 ± 0.01 min-1 and in GC-505 
MS analysis showing a new cyclosteroid product (M+410, ~1% yield,) that contained the ∆8-506 
structure (Suppl. Fig. 4, structure 24 in Table 1). While doubtful the new metabolite converts to 507 
∆5,7 -sterol under physiological conditions, it does shows mechanistically that the ∆8-bond is not 508 
essential for CYP51 activity. In contrast, a ∆8-bond in the CYP51 substrate is required in plant 509 
and animal sterol biosynthesis [41-43]. Except for cycloeucalenol as substrate, there was general 510 
agreement between affinity and catalytic competence determined by the sterol difference spectra 511 
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and binding constant (Kd) and efficiency for substrate to be converted to 14-desmethyl product 512 
(kcat). Those substrates having a 9,19-cyclopropyl group, typical of intermediates in the plant 513 
sterol biosynthesis pathway, poorly bind to the enzyme (cycloeucalenol) or not at all 514 
(cycloartenol  and 24(28)-methylene cycloartanol). Structural isomers of the cyclopropyl sterol 515 
that possess a ∆7-bond do not bind while those that possess a ∆8-bond bind well with obtusifoliol 516 
(Suppl. Fig 3- 10) the apparent favored substrate for AcCYP51. While not readily evident from 517 
the affinity constant (Kd), but apparent from the rate data (kcat) through comparison of pairs of 518 
substrates that differ in side chain construction for a ∆24(28) –group of lanosterol (Suppl. Fig. 3 - 519 
33) versus eburicol (Suppl. Fig. 3 - 32), obtusifoliol (Suppl. Fig. 3- 10) versus 31-norlanosterol 520 
(Suppl. Fig. 3- 37), it appears that AcCYP51 prefers a substrate that possesses the 24(28)-bond 521 
(Table 2) consistent with its phylogenetic association to land plant enzymes [6] and provides 522 
rationale for the biosynthetic ordering of intermediates.  523 
Thus, in good agreement with results of the titration experiments and catalytic parameters of the 524 
AcCYP51 the enzyme clearly prefers obtusifoliol (Table 2) yielding an optimal rate for C14-525 
demethylation of 7.6 min-1. The value is close to the Vmax reported for kinetoplastid protozoan 526 
and land plant CYP51and is approximately 6 fold lower than those for the fungal and human 527 
isoforms [6]. On the basis of the previously determined catalytic competence of cloned AcSMTs 528 
(referenced in Table 2), it has been shown cycloartenol [kcat 1.5 min-1/Km 44 µM] is the favored 529 
substrate for 24-SMT and the enzyme generated product is 24(28)-methylene cycloartanol while 530 
24(28)-methylene lophenol [kcat 0.8 min-1/ Km 25 µM] is the favored substrate for 28-SMT which 531 
converts to multiple 24-ethyl sterol ∆25(27) - and ∆24(28) - products [33]. Comparative analysis of 532 
the sterol C14-demethylase and C24-methylase specificity reveal neither of the AcSMT 533 
recognizes obtusifoliol as substrate and that AcCYP51 fails to productively accept either of the 534 
AcSMT favored substrate.  535 
3.4. Identification of a new sterol biosynthesis in protozoa; evidence for separate intermediates 536 
to C28 - and C29-sterols.  537 
There is no clear information about the C29-sterol synthesis pathway. In the first round of 538 
trophozoite sterol analyses, we identified 15 neutral sterols (other than the novel aromatic 539 
sterols) from the MgCl2 treated cultures (compounds 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 17, 18 540 
and 20, Suppl. Fig. 2 and 3) and from logarithmic phase cultures 4 more sterols were detected 541 
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(Suppl. Fig 1 16, 19, 21 and 27 and illustrated in Suppl. Fig. 3) while additional sterols were 542 
obtained from treated cultures corresponding to many of the compounds previously isolated from 543 
Acanthamoeba polyphaga, including cycloartenol, 24(28)-methylene cycloartanol, obtusifoliol, 544 
24β-ethyl cholesterol and 24β-methyl cholesterol [28, 29]. Our chemical identification of Ac 545 
cycloartenol by GC-MS against a standard available to us and of parkeol synthesized from 546 
cycloartenol by acid-induced rearrangement of the cyclopropane ring to the 9(11)-structure [44] 547 
agrees with the careful biochemical and enzymological studies of Rohmer showing as well that 548 
cycloartenol is the sole product of 2,3-oxidosqualene cyclization to protosterol in A. polyphaga 549 
and 9(11)-metabolites occur as byproducts in trace amounts [28, 29]. Our observations combined 550 
with that of Rohmer for cycloartenol rather than lanosterol as the true protosterol for 551 
Acanthamoeba species is supported by Ac genome mining for sterolic enzymes where a single 552 
2,3-oxidosqualene to protosterol synthase (cyclase) is detected corresponding to the cycloartenol 553 
synthase (CAS1). Recent phylogenetic studies have shown that CAS1 can be distinguished from 554 
the gene for lanosterol synthase (LAS1) through a signature peptide sequence with a conserved 555 
residue at amino acid position-442 (Ac numbering system) for isoleucine rather than valine 556 
characteristic of the lanosterol synthase (LAS1), as shown in supplemental Figure 7 [13, 45 and 557 
references cited therein]. Testing effects of substitution of the conserved residues in and around 558 
position 442 (Ac numbering) on CAS1 and LAS1 have led to the notion that high conservation of 559 
the amino acid composition in these regions represents an important structural basis for 560 
evolutionary conservation of protosterol formation [13], and indicate that cycloartenol evolved 561 
before lanosterol.   562 
For elucidation of new biochemical transformations and biosynthetic pathways mass spectra of 563 
sterols identified in GC-MS analysis are extremely powerful tools in providing information about 564 
multiple structural features of the molecule. In many cases authentic compounds are recorded in 565 
the recently released NIST library of chemical standards. A molecular ion is normally observed 566 
in the mass spectrum of free sterol which is reason we have studied this sterol form in GC-MS 567 
analysis. It is preferable to consider fragmentation patterns and subtleties in ion intensity 568 
associated with the ring and side chain in formulating sterol structure [46]. For those that rely on 569 
the NIST library to assign structure to sterols caution should be exercised since partial 570 
information is obtained from observation of molecular ion and base peak of target sterol as 571 
match indicators and thus can lead to erroneous structure assignments for several key compounds 572 
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as reported in reference 34. Importantly, many reference sterols that occur naturally are not 573 
entered into the NIST library. For example, the aromatic sterols identified in this study, e.g., 574 
amebasterol-1 of M+ 394 amu, is matched to 9-methyl anthrasteroid (anthraergostatraenol) in the 575 
NIST library with 81.1% match of 86.7 % probability. This seemingly excellent match in the 576 
database generates an incorrect structure for the Ac compound while the correct structure has yet 577 
to be deposited into the NIST library. Indeed, Rohmer proved through NMR studies, and 578 
confirmed here, the structure of this Ac metabolite as the phenanthrene skeleton harboring an 579 
aromatic B-ring with the C19 methyl rearranged to the C6-position [31]. Another relevant 580 
example for potential inaccuracy in structure determination as it relates to Ac sterol biosynthesis 581 
pathways comes from the supposed mass spectrum match of ergosterol which has the ∆5,7,22 -582 
triene system. Its ∆25(27) -ergostene isomer, like that of its ∆24(28) - and ∆24(25) -ergostene isomers, 583 
have identical mass spectra and one of more of these isomers can co-elute with ergosterol in GC 584 
unless appropriate chromatographic conditions are met [19, 46]. Referencing the NIST library is 585 
further limited in the identification of the set of B-ring structural isomers of ∆8 versus ∆7-586 
ergostenes, for the set of conjugated B/C-ring dienes of ∆5,7(8), ∆8,14(15), ∆5,8(9), ∆6,8(14) -ergostene 587 
isomers and for the C24-alkyl epimers (for example) poriferasterol (24β-ethyl) and stigmasterol 588 
(24α-ethyl) [46-49]; in the usual practice, identification of the individual isomers is confirmed 589 
through a comparison of chromatographic and spectral constants of the unknown as the free 590 
alcohol or as a C3-derivatized compound to assist in chromatographic resolution against 591 
equivalent data obtained on authentic standards or for determination of stereochemistry at C24 592 
through NMR of the pure compound or as necessary to synthesize the applicable standard [48].  593 
Previously isolated sterols from Acanthamoeba are variably positioned as intermediates in 594 
biosynthetic schemes for ergosterol and 7-dehydroporiferasterol synthesis, including a 595 
hypothetical terminal step whereby ∆5- C29-monoene sterols (24-ethyl cholesterol), formed from 596 
∆5,7-sterol, convert to final ∆5,22-diene sterol, as can occur in land plants. Curiously, the ∆25(27) -597 
C29-sterols that we observed in trace amounts in A. castellanii were detected also in trace 598 
amounts in A. polyphaga and A. culbertsoni by research groups with expertise in natural product 599 
characterizations [28, 50]. However, the earlier investigators failed to consider the biosynthetic 600 
importance of ∆25(27) -sterols to ergosterol and 7-dehydroporiferasterol synthesis, relegating them 601 
to by-products in the sterol metabolome. The accumulation of ergsost-5-enol and poriferast-5-602 
enol [structures 4 and 14 in Suppl. Fig. 3] which arise from the salt treatments is problematic and 603 
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may not relate to their biosynthetic intermediate role in ∆5,7-sterol formation of ergosterol and 7-604 
dehydroporiferasterol as proposed [28]. Rather, these sterols may be considered metabolically 605 
inert end products formed along with brassicasterol and poriferasterol from a ∆7-reductase of 606 
broad substrate specificity during encystment and not from trophozoite growth (Fig. 6). As our 607 
studies suggest, the ∆7-reductase appears only to be active during the encystment process.  608 
Incubation of [methyl-2H3]methionine with trophozoites revealed growth arrested cultures 609 
possessed three major isotopically labeled sterols corresponding to ergosterol, poriferasterol and 610 
7-dehydroporiferasterol; for ergosterol the mass spectrum showed the dideuterated species (M+ 611 
396 → M+ 398) while the mass spectrum of 7- dehydroporiferasterol showed the pentadeuterated 612 
species (M+ 410 → M+ 415) and the mass spectrum of poriferasterol showed the 613 
pentadeteuterated species (M+ 412 → M+ 417) (Figure 2, Panels E and F). The fragment 614 
containing the high end molecular cluster at m/z 396 for ergosterol and m/z 410 for 7-615 
dehydroporiferasterol derived from the methyl cation on SAM was shifted by 2 Da or by 5 Da, 616 
respectively, in the mass spectra of the labeled sterol (Suppl. Fig. 8) These labeling results show 617 
a mixed biosynthetic pathway in which ergosterol is formed by an ∆24(28) - sterol methylation 618 
pathway similar to land plants which incorporate 2 D-2H3-SAM atoms at C28 while the 7-619 
dehydroporiferasterol and poriferasterol sterol C29-methylation pathways are similar to the ∆25(27) 620 
–C29-sterol methylation pathway in green algae which incorporate 5-D 2H3-SAM atoms into the 621 
C29-sterol [19, 45]. In contrast, land plant C29-sterol biosynthesis 4D 2H3-SAM atoms are 622 
incorporated into the 24-ethyl group consistent with the involvement of a ∆24(28) -C29--sterol 623 
intermediate [51]. The enzyme-catalyzed conversion of ∆24(25) -sterol substrate to C28- and C29-624 
sterol products were considerably altered from the sterol profile of control. As shown (Figure 2, 625 
Panel B), the composition of the sterol mixtures obtained from cultures grown on normal and 626 
deuterium-labeled methionine showed that the proportion of C28-sterol was markedly increased 627 
while the C29 sterols decreased in the cultures grown in the presence of [methyl-2H3]methionine. 628 
These labeling experiments reveal the operation of a pronounced deuterium isotope effect and 629 
indicates that the proton loss from a C28 intermediate (Figure 5, Panel A) is the rate-limiting step 630 
in formation of C29-sterol products. Thus, in the presence of substrate 28-SMT affording C29-631 
sterols can in some circumstances significantly alter the course and equilibrium of metabolic 632 
sequences affecting the balance of C28 to C29-sterols during growth and differentiation. For C29-633 
sterols there is switch to an alternate route utilizing ∆25(27)-intermediates in contrast to the 634 
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previously reported route of ∆24(28) -intermediates [28]. It should be remembered the cell pellet 635 
used for our sterol analysis was from a culture composed of two populations of cells—636 
trophozoites that synthesize ∆5,7 -sterols and encysted cells that contain ∆5- sterols. Given the 637 
differentiation processes discussed in section 3.1, it is more likely the poriferasterol is derived 638 
from the 7-dehydroporiferasterol associated with trophozoite to encysted cell formation. It is also 639 
notable the phytosterols synthesized in land plants possess side chain C24/methyl/ethyl 640 
structures that are α-oriented while our 1HNMR analysis of the A. castellanii ergosterol and 7-641 
dehydroporiferasterol indicated the C24-methyl/ethyl structures are β-oriented similar to the side 642 
chain structures of C28-and C29- sterols in the green alga Chlamydomona reinhardtii [19].  643 
Conventional co-metabolite ordering in Ac sterol biosynthesis suggests the amoeba operates a 644 
land plant phytosterol biosynthesis pathway via the cycloartenol to 24(28)-645 
methylenecycloartanol ∆24(28) -pathway to C28- and C29-sterol final products. However, through a 646 
comparison of the Ac genomic database with land plant (Arabidopsis) genomic database (and for 647 
aromatase the human genome database) together we our chemical analysis of trophozoites and 648 
encysted cells, we reconstructed the cycloartenol to 6-methyl aromatic sterol biosynthetic 649 
pathways, taking into account phylogenetic differences in the sterol methylation of ∆25(27) – 650 
(green algae) and ∆24(28) -olefin (land plant) routes and in the formation of ∆5,7- sterols versus ∆5-651 
sterols  (Fig. 6). The reconstruction of the A. castellanii sterol pathway underscores the 652 
metabolic divergence of amoeba and recurrent evolution. The results  show: (i) completion to a 653 
∆5-monoene sterol atypical of green algae, (ii) selective sterol methylation for the 24β- 654 
orientation typical of green algae (iii) in vitro AcSMT assays show obtusifoliol is not a substrate 655 
and that ∆25(27) –sterol is a product of the enzyme catalyzed reaction consistent with ordering of 656 
intermediates based on biosynthetic reasonableness, and (iv) 2H-methinone fed to Ac show the 657 
C28 - and C29- sterol products are formed by separate ∆24(28) – C24-methylene and ∆25(27) -olefin 658 
C24-ethyl intermediates, respectively, and that any ∆24(28) -24-ethyl sterols formed enzymatically 659 
are redundant not incorporated into 7-dehydroporiferaterol under physiological conditions.  660 
3.5. Dependence of inhibitor effect on the physiological state of the amoeba cells 661 
The primary mechanism of the azole and steroidal inhibitor effect- inhibition of ergosterol 662 
biosynthesis in amoeba cells- has as a prerequisite an active cellular metabolism for the 663 
biosynthetic renewal of ergosterol with proliferation and growth. It is understandable that 664 
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dormant cysts could only be affected at high concentrations of these drugs (>100 µM), if at all. 665 
However, unclear is the extent to which the encysted cell can alter its sterol profile in response to 666 
an ergosterol biosynthesis inhibitor. The aza analog of the C25-carbocation intermediate of the 667 
C24-methylation reaction, a steroidal inhibitor, against Ac24SMT and Ac28-SMT and the tight 668 
binding inhibitor voriconazole against AcCYP51 were utilized to determine the relative 669 
importance of active site interactions of select sterol biosynthesis enzymes responsive to these 670 
drugs in vitro as well as in cell-based studies 671 
The effect of azole and 25-azacycloartanol (Fig. 7, Panel A) on rapidly proliferating trophozoites 672 
was much the same—both compounds prevented amoeba growth at low inhibitor concentrations 673 
of IC50 values 390 nM and 25 nM, respectively and MAC values between 1-3 µM (Fig. 7, Panel 674 
B). Sterol analysis of mostly encysted cells revealed mark changes to the C28- and C29- sterol 675 
balance associated with encystment (Suppl. Fig. 2, Panel C and Suppl. Fig. 9) and the total sterol 676 
content was less than in trophozoite by approximately 50% on per cell or pellet basis.  Although 677 
steroidal inhibitor treatment resulted in reduced C29-sterol levels, showing disruption in substrate 678 
pools, there was not much accumulation of intermediates cycloartenol or obtusifoliol, suggesting 679 
a down-regulation of de novo sterol synthesis as trophozoite converts to encysted cell as reported 680 
elsewhere [35]. In neither treatment was there significant accumulation of 6-methyl aromatic 681 
sterol. However, after the treated cells were incubated for another 8 days all the ∆5,7-sterol had 682 
converted to 6-methyl aromatic sterol accompanied by a ten- fold decline in fresh weight of the 683 
pellet.  When the concentration of inhibitor is increased 10 to 50 fold, i.e., increasing stress, the 684 
resulting 48 cell pellet is composed exclusively of dead cells and the sterol profile consists 685 
mostly of 6-methyl aromatic sterol.  686 
To determine whether FUdR, a DNA synthesis inhibitor [52] that should prevent ergosterol 687 
biosynthesis globally, had an effect on differentiation, spontaneous encystment was evaluated 688 
after the cultures containing inhibitor reached stationary phase of control. The resulting cells had  689 
a population of cysts equal to the parent trophozoite inoculum of approximately 2-3 x105 690 
cells/ml. Effectively all of these encysted cells (>95%) were alive according to trypan blue 691 
staining. The FUdR treated cells showed a significant increase in ∆5-sterol of brassicasterol and 692 
poriferasterol (40 % total sterol) which associates with true cyst formation (Suppl. Fig. 10). In 693 
contrast, for treatments with voriconazole or 25-azacyloartanol the number of cells at 48 h was 694 
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reduced by a factor of 10 to 2-3 x 104 cells/ml, most were dead by trypan blue staining (Fig. 7, 695 
Panel B) and they (encysted cells) possessed mostly ergosterol and 7-dehydroporiferasterol 696 
(Suppl. Fig. 9) with no accompanying 6-methyl aromatic sterol.    697 
Time-killing experiments were carried out by the addition of inhibitor at approximate MAC 698 
levels to the culture medium for 48 incubations. Figure 7 (Panel C) shows that medium 699 
inoculated with a population of 1 x 105 cells/ml trophozoites (90%) affords continued 700 
trophozoite proliferation, without significant encystment (data not shown), to a stationary phase 701 
population of  1 x 106 cell/ml. Alternatively, in the presence of the test inhibitors, at about the 702 
MAC, the trophozoite population drops to zero. This stressing of amoeba stimulates trophozoite 703 
to encyst, which as inhibitor pressure is maintained yields a decrease in the total number of 704 
encysted cells from approximate 3 x 104 encysted cells/ml at 12 h to an approximate 5 x102 to 5 705 
x103 cells/ml at 48 h growth. Trypan blue staining of the encysted cells revealed two dominant 706 
populations characterized by those that are viable or non-viable and dead. When the 48 h treated 707 
pellets were transferred to fresh medium and incubated for a week, 25-azacycloartanol 708 
treatments showed no growth while from the voriconazole treatment a few thousand trophozoites 709 
were evident, suggesting the predominant population of encysted cells viewed as dead by trypan 710 
blue staining were indeed dead in terms of excystment.  711 
Because the clumped cells were in much greater density in treated cells than in control, it was 712 
straightforward to examine them by scanning electron microscopy (SEM) and transmission 713 
election microscopy (TEM). Thus, SEM and TEM images of 25-azacycloartanol-generated cysts 714 
(VOR looked much the same) from the 48 h harvest were virtually the same as those of control 715 
cysts originating in T-flasks showing one or more flaccid cells clumped together with rounded 716 
cells (cf. Figure 2, Panel C). Fine structure of the treated cells also showed a deformation in cell 717 
wall associated with an aberrant thickening or partially formed ectocyst and endocyst, and the 718 
cell interior looked severely damaged with (i) formation of blebby structures in the cell 719 
membrane, (ii) broken membrane structures and (iii) intense vacuolization and loss of 720 
mitochondria typically associated with autophagy-like structures in the center of the cell that 721 
contained undigested organelle.  722 
To determine whether inhibitors designed to block two essential enzymes in the post-squalene 723 
segment of the ergosterol biosynthesis pathway are more potent in combination than when added 724 
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to the medium singly, we monitored the effects of combining subinhibitory concentrations of one 725 
drug against varied concentrations of the other drug on trophozoite multiplication. Complete 726 
eradication of the amoeba parasite is obtained when using the drugs in combination at 727 
concentrations as low as equal to their IC50 values which in our studies for voriconazole was 140 728 
nM ± 10 nM compared to our previously reported 390 nm [32] and for 25-azacycloartanol is 25 729 
nM ± 2 nM (Fig. 7, Panel D). The number of dead cells at 48 h in the combination drug 730 
experiment of 25 nM 25-azacycloartanol (25 nM) and voriconazole (100 nM) was similar to the 731 
number of dead cells when the drugs were administered individually to the medium (Fig. 7, 732 
Panel B), and no trophozoites were detected after 5 days following resuspension of treated pellet 733 
into fresh medium. These results suggest that combined treatment of two or more rationally 734 
designed inhibitors at sub-MAC concentration can successfully interfere with sterol biosynthesis 735 
to prevent leakiness at the target enzyme and in so doing limits production of the downstream 736 
C28- and C29-sterols, supporting a role for AcCYP51 and AcSMTs in the control of metabolic flux 737 
through distinct intermediates. 738 
3.6 Excystment in response to inhibitor treatment. 739 
In a separate experiment the anti-amoeba effect of the drugs on excystment was determined with 740 
cysts derived from the SDS-treated process. Using MAC concentrations of the ergosterol 741 
biosynthesis inhibitors, all the resting cysts convert to trophozoites by 5 days, indicating that 742 
excystment is insensitive to these treatments. In similar fashion, the FUdR treated resting cells 743 
easily excysted into trophozoites by 3 days. During these experiments, increase numbers of 744 
empty cyst walls were evident in cell mixture, consistent with excystment.  745 
3.7. Enzymatic basis of action and selectivity. 746 
All the available experimental evidence indicates that AcCYP51 and 24-/28-AcSMT are the 747 
primary target of the medical azole and steroidal N-inhibitor, respectively, since we observed 748 
small accumulations of obtusifoliol and cycloartenol in the presence of voriconazole and 749 
24(R,S),25-epiminolanosterol [32, 33]. The target enzymes were characterized from cloned genes 750 
introduced into E. coli and solubilized for activity assay. In our earlier study, we observed that 751 
voriconazole is a specific and reversible inhibitor of AcCYP51 exhibiting an IC50 of 390 nM and 752 
its MAC is approximately 3 µM [32, 33]. 25-Azacycloartanol tested as a true substrate analog 753 
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inhibitor is approximately as effective against 24-AcSMT and 28-AcSMT as voriconazole 754 
against AcCYP51. The inhibitor against trophozoite proliferation generates an IC50 of 25 nM ± 755 
0.25 nM and MAC of 1 µM ± 0.05 µM (data not shown) and against 24-SMT incubated with 756 
cycloartenol as substrate or 28-SMT incubated with 24(28)-methylene lophenol as substrate 757 
yields IC50 values of 15 nm (Ki = 13 nM) and 22 nM (Ki = 8 nM) (Suppl. Fig. 11). The measured 758 
inhibition of the AcCYP51 and SMT activities is quantitatively sufficient to account for the 759 
inhibition of ergosterol and 7-dehydroporifersterol biosynthesis in amoeba.  760 
3.8. Effect of Acanthamoeba sterols on growth of GL7 761 
To assess the structural specificity for sterols as membrane inserts directly, we used the yeast 762 
GL7 auxotrophic for sterol. Close interactions between sterol supplementation and the growth 763 
response was detected. Ergosterol supplementation to GL7 afforded growth arrest in 72 h 764 
affording approximate 1 x 108 cells/ml, typical of wild-type yeast, while cultures without added 765 
ergosterol yielded a no growth-response, as reported previously (Fig. 8) [8, 39, 53]. Ergosterol 766 
was recovered in unchanged form from the cells at approximately 20 fg/cell. Microscopic 767 
examination showed the GL7 yeast at growth arrest revealed mostly single cells or those that 768 
were undergoing budding. Alternate sterol supplements fed to GL7, 7-dehydroporiferasterol, 769 
brassicasterol, poriferasterol reached a stationary phase of 1 x 108 cells/ml similar to the 770 
ergosterol fed cells and each of the sterols was recovered from cells in unchanged form at 20 771 
fg/cell. Alternatively, cells fed the 6-methyl aromatic sterol supplement failed to proliferate by 772 
72 and microscopically many cells were clumped or dead by trypan blue staining typical of yeast 773 
cultured on a steroidal inhibitor [53]. Past interpretation using the GL7 system showing a no 774 
growth response following administration of nutritionally adequate amounts of sterol is the 775 
supplement failed to adequately fit the membrane structure [7, 8]. 776 
 777 
 778 
 779 
 780 
 781 
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DISCUSSION 782 
In spite of the therapeutic importance for an exacting sterol composition in parasitic protozoa 783 
[27], relatively little is known about the regulation and function of phytosterols in amoeba. This 784 
lack of information on metabolic controls is a serious impediment to the development of 785 
strategies for targeted inhibition of phyla-specific enzymes, such as the sterol C24-methylase, 786 
that can occur in the protozoan pathogen while absent from the human host. Previous functional 787 
and phylogenetic analysis of amoeba steroidogenesis has left the role and origins of C28- and C29- 788 
sterols somewhat opaque. In particular, while it seems clear the Acanthamoeba can synthesize 789 
ergosterol and 7-dehydroporiferasterol, it has been assumed there is one set of terminal 790 
compounds – ∆5,7-sterols - that act unaltered as membrane inserts and for the sterol biosynthetic 791 
genes to be descended from plants.  However, the possibility for evolutionary accommodation of  792 
stage-specific differences in ∆5-, ∆5,7- and 6-methyl aromatic compounds in Acanthamoeba was 793 
indicated by GC-MS analysis of mixed populations of trophozoites and encysted cells, although 794 
it was ignored, leading to the view that ∆5- sterols are the precursor of ∆5,7-sterols, that the C24-795 
methylation ∆24(28) -route typical of land plants yield intermediates for the synthesis of C28- and 796 
C29-sterols and for the sterolic enzymes to lack substrate specificity affording criss-crossing 797 
routes of major and minor biosynthesis pathways to final ∆5,7-sterol products [2, 29, 54]. 798 
Subsequent co-metabolite and phylogenetic analysis based on an erroneous characterization of 799 
many of the reported amoeba sterols, incorrect bioinformatic analyses for identity of the 2,3-800 
oxidosqualene cyclase as lanosterol synthase and failure to report a SMT2-type isoform required 801 
in the synthesis of 24-ethyl sterols [34] developed an enigmatic history for Acanthamoeba 802 
ergosterol biosynthesis pathway as originating with the fungi.  803 
Here and in our previous paper [33] we provide evidence for the first time that indicates the 804 
sterol biosynthetic enzymes in Acanthamoeba were composed of catalytically constrained 805 
participants of strict substrate specificity, for sterol methylases to be responsible for generating 806 
distinct ∆24(28) - and ∆25(27) -olefin intermediates that convert to functional C28- and C29-sterol 807 
products of varied nucleus structures and that the conventional sterols typical of protozoa 808 
ergosterol and 7-dehydroporiferaterol can be replaced with the uncommon brassicasterol-809 
poriferasterol and amebasterol-1 and amebasterol-2 steroidal pairs during the encystment phase 810 
of the amoeba life history. Because methylation patterns in large part determine product 811 
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outcome, subtle alterations in methyltransferase substrate selectivity have a profound impact on 812 
the balance of C28- and C29-sterols, which was noted following inhibitor treatment. The step-wise 813 
alteration in the sterol compositions observed during a normal excystment-encystment cycle 814 
yielding ∆5-sterols and 6-methyl aromatic sterols from a ∆5,7-sterol parent compound is not 815 
consistent with the limited sterol diversity in protozoa, rather it supports a simple model of 816 
cryptic unikont evolution not necessarily observed in the bikont amoeba Naegleria wherein a ∆5,7 817 
–sterol biosynthetic renewal is crucial to trophozoite proliferation, ∆5-sterol synthesis is essential 818 
for the production of a resting cyst capable of excystment and 6-methyl aromatic sterols, derived 819 
from ∆5,7-sterols in encysted cells considered non-viable for excystment, promote cell lysis and 820 
death as outlined in the proposed model of Acanthamoeba sterol biosynthesis and function 821 
shown in Figure 9.  822 
Comparing the ontogenetically regulated sterol compositions in trophozoites and encysted cells 823 
and catalytic analysis of relevant chokepoint enzymes AcCYP51 and AcSMT is phylogenetically 824 
interesting yet connects to the functional importance of sterol products through modified 825 
structural features that occur in the stage-specific furnished molecule. Thus, proliferating 826 
trophozoites synthesize C28- and C29-∆5,7-sterol products typical of kinetoplastids, such as 827 
Trypanosma cruzi, and the green algae synthesize ergosterol and 7-dehydroporiferasterol [19, 20, 828 
57] but these organisms synthesize the C28- and C29-sterols through different biosynthesis routes. 829 
It appears AcCYP51 possesses substrate preference and catalytic competence more like that of 830 
plant, and hence protozoa, than of fungal or human CYP51 [6]. The substrate specificity of 831 
AcCYP51 places C14-demethylation after the first sterol methylation step (Fig. 6). However, 832 
while T. cruzi has a single SMT1 which is ∆24(25) - and ∆24(28) -substrate bifunctional capable of 833 
generating a single ∆24(28)-Z ethylidene C29 – product [55-57] and green alga SMT is substrate 834 
bifunctional capable of generating a single ∆25(27)-C29-sterol product [8], A. castellanii has two 835 
SMTs to carry out these sterol methylations at C24 with the second methylation step yielding the 836 
24β-stereochemistry. As we discovered in this investigation through isotopically labeling studies 837 
to amoeba, the AcSMT2 (or 28-SMT) can, unlike the T. cruzi SMT1, synthesize the C29-∆25(27) -838 
olefin outcome and the resulting intermediate is precursor to the 7-dehydroporiferasterol and 839 
poriferasterol. Fungi, on the other hand, synthesize a single SMT1 operating the ∆24(28) -route 840 
specific for zymosterol and ergosterol while land plants possess two SMTs and both operate the 841 
∆24(28) –route such that separate intermediates are involved in the formation of  C28α-campesterol 842 
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and C29α-sitosterol, respectively [20]. The lineage-specific recurrence of an ancient ∆25(27) -sterol 843 
metabolic pathway affording primitive 24β-ethyl sterols in the unikonts suggest divergence with 844 
the ancestral SMT occurred independently multiple times during the course of eukaryote 845 
evolution and within the protozoa product-specific families of SMTs evolved unique to the 846 
Acanthamoeba. The notion of divergent evolution rather than convergent evolution for the 847 
amoeba SMTs is supported by the conservation of sequence similarity and gene structure among 848 
the diverse SMTs isolated throughout the eukaryotic domain to date [8, 59, 60].  849 
The results of studies carried out so far on stage-specific sterol profiling in Acanthamoeba and 850 
for GL7 growth responses to sterol supplementation lead to the important conclusion that the 851 
membranes of trophozoites and resting cysts have certain structural requirements for sterol that 852 
are remarkably similar to yeast. They are clearly associated with the three-dimensional character 853 
of the molecule since C28- and/or C29-sterols are consistently found in the cells. In the 854 
trophozoite and resting cyst, the sterols possess a double bond in ring B of ∆5,7-bond 855 
(trophozoite) or ∆5-bond (resting cyst). The terminal formation of ∆5- sterols could represent a 856 
fine tuning in nucleus planarity but the structural change does not qualify for a significant effect 857 
on membrane fluidity. We surmise the conserved metabolism of ∆5,7-sterols to form a ∆5-sterol 858 
relates to its homoallylic effect on the C-O bond at C3. For the ∆5-sterol, donation of electrons 859 
through an inductive effect, analogously to the well-studied 3,5-cyclosteroid rearrangement, 860 
should strengthen the H-O bond and therefore weaken somewhat and fine-tune any hydrogen 861 
bonding of the sterol to phospholipid in the lipid leaflet of the resting cyst. It should be 862 
remembered that steric interference from C4-methyl groups on the hydrogen bonding ability of 863 
C3- group can weaken sterol-lipid interactions and therefore is reason for removal of C4 to 864 
generate an acceptable sterol membrane insert.  865 
In depending upon ∆5,7-sterols to act as the encysted cell sterols, it is important not to overlook 866 
these cells are on a trajectory for lysis and death, which associate with rapid turnover of the ∆5,7-867 
sterol, now as intermediates, to a 6-methyl aromatic sterol; cell death from these sterols is 868 
observed in GL7 growth experiments as well. The B-ring aromatic sterols effectively replace 869 
∆5,7-sterols as the membrane component. It appears the architectural unsuitability of the 870 
phenanthrene sterols stems mainly from their diminished hydrogen-bonding strength of the C3-871 
group resulting from the altered electronegativity of the polar group affected by the double bond 872 
30 
  
conjugations in the nearby aromatic ring. This is consistent with their less polar chromatographic 873 
character in TLC observed too for 4-methyl sterols relative to 4-desmethyl sterols. Alternatively, 874 
contribution from the π-lobe negativity in the B-ring could minimize Van der Walls’ forces, 875 
disrupting lipid flexibility in the plasmamembrane.  876 
Apart from these considerations and relevant to our research program in rational drug design [27, 877 
33, 58], a major question brought forward by the developmentally regulated sterol biosynthetic 878 
enzymes of Acanthamoeba is to what extent they are exploitable by chemotherapy as the relevant 879 
sterol nucleus demethylase enzyme in Acanthamobea differs critically from those of its human 880 
host and the substrate requirements for sterol side chain methylases are unlike any of those for 881 
enzymes in the cholesterol biosynthesis pathway. Thus, the CYP51 and SMT enzymes in 882 
amoeba ergosterol biosynthesis represent potential species-specific drug targets. These enzymes 883 
at MAC concentrations of approximate 1 µM generate trophozoite kill, with the remaining viable 884 
cysts following excystment lysing as the inhibitor pressure continues. Although trophozoite kill 885 
is foremost the focus of our research, prevention of viable cysts that contain brassicaterol and 886 
poriferasterol is also relevant. In the latter case, the possibility for a transcriptional up-regulation 887 
of active ∆7-reductase affecting the conversion of ∆5,7 - to ∆5 -sterol during encystment and its 888 
impairment by an appropriate sterol biosynthesis inhibitor would, in combination therapy with 889 
azole or steroidal inhibitor, enable prevention or cure of diseases from Acanthamoeba. It could 890 
be as well the dramatic change in sterol profiles are a combination of anabolic and catabolic 891 
processes since the current study focuses on providing measurements of steady levels of 892 
particular sterols and are not measuring dynamic changes associated with biosynthesis. Further 893 
work is warranted to determine whether additional sterol metabolites or derivatives contribute to 894 
the changes noted in sterol-controlled encystment events and whether their formation are 895 
differentially sensitive to sterol biosynthesis inhibitors.   896 
Conclusions. 897 
To summarize the evidence, our findings revealed a new C29 ∆25(27) -sterol pathway in protozoa 898 
showing a phylogenetic closeness of Acanthamoeba to green alga and provide a powerful 899 
strategy to enhance anti-amoeba efficacy using combinations of azole and steroidal inhibitor to 900 
render resistant amoeba pathogens responsive to ergosterol biosynthesis inhibitor treatment. The 901 
capacity of steroidal inhibitors yet to be discovered (e.g., ∆7-reductase inhibitor) to modulate 902 
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core encystation pathway yielding non-viable cells destined to die overcomes a major challenge 903 
for small molecule efficacy against the cysticidal effects of drugs necessary to prevent recurrence 904 
of the disease. The potency of tight binding inhibitors against A. castellanii target enzymes was 905 
confirmed by time-kill curves and through encystment-excystment assays. Finally, strict 906 
structural specificities for ∆5,7 - and ∆5-sterols in the autophagic stage of encystment correlated to 907 
altered membrane structures of encysted cells yielding non-viable or viable cysts; the 6-methyl 908 
aromatic sterols represent chemical signatures for amoeba death accordingly these compounds 909 
can be medical diagnostics.  910 
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Figure 1. Sterol biosynthesis diversity in eukaryote organisms. 1073 
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Figure 2. Developmental changes in A. castalenii growth and sterol biosynthesis. Panel A, 1091 
Proliferation of trophozoites from a true cyst inoculum. Panel B, Total ion current 1092 
chromatograms of neutral lipids of trophozoites (green), true (viable) cysts (blue) and dead cells 1093 
(red); GC peaks correspond to 1= brassicasterol, 2=ergosterol, 6=poriferasterol, 11=7-1094 
dehydroporiferasterol, 15= amebasterol-1 and 26 = amebesterol; inset shows quantitative 1095 
changes in the population of encysted cells to trophozoite to dead cells. Panel C, C1-light 1096 
micrograph (LM) of double wall viable cyst used as inoculum with rounded outer wall ectocyst 1097 
(EC) and inner wall endocyst (EN), C2-scanning electron micrograph (SEM) of cyst in the 1098 
process of excystment., C3- Transmission electron micrograph (TEM) of true cyst showing 1099 
diagnostic mitochondria (M) and autolysosomes (A). C4-LM of trophozoite, C5-SEM of 1100 
trophozoite showing acanthapodia. C6 TEM of trophozoite showing prominent central 1101 
nucleolous (n), mitochondria and cytoplasmic food vacuoles. C7-LM of trypan blue stained 1102 
clumped encysted cells showing many dead. C8- SEM of clumped encysted cells of control or 1103 
25-azacycloartenol treated trophozoites showing deflated (DF) cell characteristic of dead cells. 1104 
L9- TEM of encysted trophozoite from L8 samples showing ectocyst-endocyst boundary and 1105 
abnormal morphological features of autophagy-like structures that contain undigested organelles 1106 
(arrow), blebby structures in the membranes (B, arrowheads) and disorganized membrane 1107 
structures (D, arrowhead), intense vacuolization and loss of mitochondria. 1108 
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Figure 3. Chromatographic and spectral characteristics of main Acanthamoeba sterols from the 1110 
growth studies shown in Figure 2.   1111 
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Figure 4. GC-MS analysis of the AcCYP51-generated products. (A) The total ion current 1124 
chromatogram (insert- mass spectra of relevant GC peaks) of incubation with obtusifoliol. (B) 1125 
The total ion current chromatogram (insert-mass spectra of relevant GC peaks) of incubation 1126 
with cycloeucalenol.  1127 
 1128 
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Figure 5. Sterol C24-methylation activity in Acanthamoeba. (A) Proposed sterol C24-1138 
methylation pathway in Acanthamoeba showing incorporation of SAM and [methyl-2H3]SAM = 1139 
D3-SAM at C24 and C28 of the sterol side chain. (B) Mass spectral analysis of sterols 1140 
(ergosterol, erg, poriferasterol, por, and 7-dhydroporiferasterol, DHP) recovered from 1141 
trophozoites incubated in the presence and absence of [methyl-2H3]methionine. 1142 
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Figure 6. Biosynthetic model for the formation of phytosterols in Acanthamoeba. (A) Proposed 1157 
separate ∆24(28) - and ∆25(27) -olefin intermediates to C28- and C29-sterol products. (B).  Sterolic 1158 
genes identified in the Ac Genebank compared to known sterolic genes from land plants and 1159 
humans (aromatase). 1160 
 1161 
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 1164 
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Figure 7. Effects of ergosterol biosynthesis inhibitors as single or combination treatment on 1170 
Acanthamoeba growth and encystment prepared by Method-1 (Materials and Methods). Panel A, 1171 
structures of growth inhibitors. Panel B, Time-kill studies of 25-azacycloartanol (AZC) and 1172 
voriconazole (VOR). Panel C, Quantification of AZC treated cysts (viable and clumped non-1173 
viable) and dead cells determined microscopically and by trypan blue staining. Panel D. A. 1174 
castellanii treated with VOR and AZC at the previously determined IC50 concentration and then 1175 
using the pair of compounds at varied concentration of the inhibitor from 16 nM to 3 µM. Data 1176 
represent mean ±sd. P < 0.05, determined by T-test. In each case data are from a single 1177 
experiment which is representative of three independent experiments. 1178 
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Figure 8. Saccharomyces cerevisiae strain GL7 defective in ergosterol biosynthesis incubated 1191 
with nutritional sterols supplements as described in Materials and Methods; ergosterol (black 1192 
circle), 6-methyl sterol aromatics from A. castellanii (orange circle) or no sterol (blue circle). 1193 
Note, 7-dehydroporiferasterol, brassicasterol and poriferasterol supplements supported growth in 1194 
similar fashion to ergosterol-grown cells.  1195 
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Figure 9. Proposed model for stage-specific sterols in growth and encystment leading to 1199 
alternate trajectories for the production of viable or non-viable cysts.  1200 
 1201 
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 1203 
